Streetbeat News

Stock Prices

TSLA

Tesla shares are trading higher following CEO Elon Musk's announcement on social media about the unveiling of the Tesla Robotaxi on August 8th, 2024.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 2:18 pm

NVDA

NVIDIA is rumored to launch its next-gen GeForce RTX 5090 & RTX 5080 'Blackwell' GPUs in Q4 2024, following the positive reception of the RTX 40 'SUPER' series. These GPUs, expected to utilize the latest GDDR7 memory, aim to push the average selling price of GPUs higher. MSI anticipates double-digit gains from these launches. The release schedule follows NVIDIA's pattern of late Q3 or early Q4 launches, though it's subject to market conditions.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 2:17 pm

COIN

Coinbase Global, Inc. (NASDAQ:COIN) shares are rising due to an increase in Bitcoin prices and positive developments including its registration as a Restricted Dealer in Canada and an upgraded price target by Oppenheimer. Despite Ark Invest selling over $21 million of Coinbase shares, the stock is trading above its 50-day moving average and near its 52-week high. Analysts have mixed views, with an average 1-year price target suggesting a downside.

Portfolio Pulse from Erica Kollmann

April 08, 2024 | 2:16 pm

GE

GE Aero (NYSE:GE) has seen a 42.68% increase in short interest, now at 12.75 million shares or 1.17% of float, with a 1.51-day average cover time. This rise in short interest indicates a more bearish market sentiment towards GE Aero, though it's below the peer group average of 2.68%. Short interest can be a complex indicator, potentially bullish if interpreted as an expectation of a price rebound.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 2:15 pm

QBTS

D-Wave Quantum (NYSE:QBTS) has seen a significant decrease in short interest, with a 40.38% drop to 5.48 million shares, representing 6.04% of its float. This reduction in short interest, which now takes traders approximately 1 day to cover, could indicate a shift in market sentiment towards a more bullish outlook for QBTS. The company's short interest is also below its peer group average of 9.00%, suggesting a relatively positive performance against its competitors.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 2:15 pm

BALL

Ball Corporation (NYSE:BALL) has seen a 5.14% increase in its short percent of float since the last report, with 10.77 million shares sold short, representing 3.89% of available shares. This indicates a bearish market sentiment towards BALL, as it takes traders approximately 5.97 days to cover their short positions. Comparatively, Ball's short interest is higher than its peer group average of 2.59%, suggesting more bearish sentiment towards Ball than its peers.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 2:15 pm

NDAQ

SHEL

Shell is contemplating a move to list its shares in New York, a decision driven by the desire for a more favorable regulatory and investment environment. This consideration comes amid growing frustrations with the current London listing, particularly regarding regulatory constraints and the investment climate. The move is seen as a way to potentially unlock greater value for shareholders and align more closely with a significant portion of its investor base.

Portfolio Pulse from Charles Gross

April 08, 2024 | 2:13 pm

SUPN

Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) received a second Complete Response Letter (CRL) from the FDA for its investigational device, SPN-830, aimed at treating Parkinson's disease. The FDA's concerns relate to product quality and the master file for the infusion device. Despite no clinical safety or efficacy issues being identified, the FDA requires additional information for approval. Supernus plans to work with the device manufacturer to address these issues. SUPN stock dropped 9% in premarket trading and closed down 1.61% at $33.01.

Portfolio Pulse from Vandana Singh

April 08, 2024 | 2:11 pm

MPWR

Monolithic Power Systems' stock (MPWR) is trading higher following Keybanc's decision to maintain an Overweight rating and increase the price target from $830 to $850.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 2:09 pm

PTN

Palatin Technologies Inc. (NYSE:PTN) announced positive Phase 3 results for PL9643 in treating dry eye disease, showing significant efficacy and safety. The dry eye disease market is expected to grow to $7.46 billion by 2029. PTN shares surged 33.1% to $2.34.

Portfolio Pulse from Vandana Singh

April 08, 2024 | 2:02 pm